FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3175269918> ?p ?o ?g. }

• W3175269918 abstract "The therapeutic indices (TIs) and efficacy of the non-steroidal mineralocorticoid receptor antagonist (MRA) KBP-5074 and steroidal MRA eplerenone were evaluated in a uninephrectomized Sprague Dawley rat model of aldosterone-mediated renal disease. In two parallel studies, rats were placed on a high-salt diet and received aldosterone by osmotic mini-pump infusion over the course of 27 days. The urinary albumin-to-creatinine ratio (UACR) was evaluated after 7, 14, and 26 days of treatment. Serum K + was evaluated after 14 and 27 days of treatment. Urinary Na + , urinary K + , and urinary Na + /K + ratio were evaluated after 7, 14, and 26 days of treatment. The TI was calculated for each drug as the ratio of the concentration of drug producing 50% of maximum effect (EC 50 ) for increasing serum K + to the EC 50 for lowering UACR. The TIs were 24.5 for KBP-5074 and 0.620 for eplerenone, resulting in a 39-fold improved TI for KBP-5074 compared with eplerenone. Aldosterone treatment increased UACR, decreased serum K + , and decreased urinary Na + relative to sham-operated controls that did not receive aldosterone infusion in both studies, validating the aldosterone/salt renal injury model. KBP-5074 prevented the increase in UACR at 0.5, 1.5, and 5 mg/kg BID while eplerenone did so only at the two highest doses of 50 and 450 mg/kg BID. Both KBP-5074 and eplerenone blunted the reduction in serum K + seen in the aldosterone treatment group, with significant increases in serum K + at the high doses only (5 mg/kg and 450 mg/kg BID, respectively). Additionally, the urinary Na + and Na + /K + ratio significantly increased at the middle and high doses of KBP-5074, but only at the highest dose of eplerenone. These results showed increased TI and efficacy for KBP-5074 compared with eplerenone over a wider therapeutic window." @default.
• W3175269918 created "2021-07-05" @default.
• W3175269918 creator A5005761311 @default.
• W3175269918 creator A5013736647 @default.
• W3175269918 creator A5014394910 @default.
• W3175269918 creator A5019321553 @default.
• W3175269918 creator A5033953205 @default.
• W3175269918 creator A5036371780 @default.
• W3175269918 creator A5046570651 @default.
• W3175269918 creator A5061827333 @default.
• W3175269918 creator A5079897101 @default.
• W3175269918 date "2021-06-24" @default.
• W3175269918 modified "2023-10-18" @default.
• W3175269918 title "The Non-Steroidal Mineralocorticoid Receptor Antagonist KBP-5074 Limits Albuminuria and has Improved Therapeutic Index Compared With Eplerenone in a Rat Model With Mineralocorticoid-Induced Renal Injury" @default.
• W3175269918 cites W1980817466 @default.
• W3175269918 cites W2000060059 @default.
• W3175269918 cites W2056194572 @default.
• W3175269918 cites W2068443525 @default.
• W3175269918 cites W2093767567 @default.
• W3175269918 cites W2121390825 @default.
• W3175269918 cites W2130827265 @default.
• W3175269918 cites W2166200293 @default.
• W3175269918 cites W2206859595 @default.
• W3175269918 cites W2466427330 @default.
• W3175269918 cites W2552263672 @default.
• W3175269918 cites W2769002571 @default.
• W3175269918 cites W2800891490 @default.
• W3175269918 cites W2805564751 @default.
• W3175269918 cites W2916456221 @default.
• W3175269918 cites W2920551789 @default.
• W3175269918 cites W2921544138 @default.
• W3175269918 cites W2945989863 @default.
• W3175269918 cites W2970833909 @default.
• W3175269918 cites W2974891745 @default.
• W3175269918 cites W2979696122 @default.
• W3175269918 cites W3000121469 @default.
• W3175269918 cites W3007380900 @default.
• W3175269918 cites W3094429645 @default.
• W3175269918 cites W4205457909 @default.
• W3175269918 cites W4376848626 @default.
• W3175269918 doi "https://doi.org/10.3389/fphar.2021.604928" @default.
• W3175269918 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8264204" @default.
• W3175269918 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34248613" @default.
• W3175269918 hasPublicationYear "2021" @default.
• W3175269918 type Work @default.
• W3175269918 sameAs 3175269918 @default.
• W3175269918 citedByCount "12" @default.
• W3175269918 countsByYear W31752699182021 @default.
• W3175269918 countsByYear W31752699182022 @default.
• W3175269918 countsByYear W31752699182023 @default.
• W3175269918 crossrefType "journal-article" @default.
• W3175269918 hasAuthorship W3175269918A5005761311 @default.
• W3175269918 hasAuthorship W3175269918A5013736647 @default.
• W3175269918 hasAuthorship W3175269918A5014394910 @default.
• W3175269918 hasAuthorship W3175269918A5019321553 @default.
• W3175269918 hasAuthorship W3175269918A5033953205 @default.
• W3175269918 hasAuthorship W3175269918A5036371780 @default.
• W3175269918 hasAuthorship W3175269918A5046570651 @default.
• W3175269918 hasAuthorship W3175269918A5061827333 @default.
• W3175269918 hasAuthorship W3175269918A5079897101 @default.
• W3175269918 hasBestOaLocation W31752699181 @default.
• W3175269918 hasConcept C126322002 @default.
• W3175269918 hasConcept C126894567 @default.
• W3175269918 hasConcept C134018914 @default.
• W3175269918 hasConcept C185592680 @default.
• W3175269918 hasConcept C189135053 @default.
• W3175269918 hasConcept C2776069600 @default.
• W3175269918 hasConcept C2776379505 @default.
• W3175269918 hasConcept C2778525890 @default.
• W3175269918 hasConcept C2780072264 @default.
• W3175269918 hasConcept C2780306776 @default.
• W3175269918 hasConcept C71924100 @default.
• W3175269918 hasConcept C98274493 @default.
• W3175269918 hasConceptScore W3175269918C126322002 @default.
• W3175269918 hasConceptScore W3175269918C126894567 @default.
• W3175269918 hasConceptScore W3175269918C134018914 @default.
• W3175269918 hasConceptScore W3175269918C185592680 @default.
• W3175269918 hasConceptScore W3175269918C189135053 @default.
• W3175269918 hasConceptScore W3175269918C2776069600 @default.
• W3175269918 hasConceptScore W3175269918C2776379505 @default.
• W3175269918 hasConceptScore W3175269918C2778525890 @default.
• W3175269918 hasConceptScore W3175269918C2780072264 @default.
• W3175269918 hasConceptScore W3175269918C2780306776 @default.
• W3175269918 hasConceptScore W3175269918C71924100 @default.
• W3175269918 hasConceptScore W3175269918C98274493 @default.
• W3175269918 hasLocation W31752699181 @default.
• W3175269918 hasLocation W31752699182 @default.
• W3175269918 hasLocation W31752699183 @default.
• W3175269918 hasLocation W31752699184 @default.
• W3175269918 hasOpenAccess W3175269918 @default.
• W3175269918 hasPrimaryLocation W31752699181 @default.
• W3175269918 hasRelatedWork W1598280036 @default.
• W3175269918 hasRelatedWork W1817639972 @default.
• W3175269918 hasRelatedWork W2009328678 @default.
• W3175269918 hasRelatedWork W2130764257 @default.
• W3175269918 hasRelatedWork W2271304487 @default.
• W3175269918 hasRelatedWork W2279875401 @default.
• W3175269918 hasRelatedWork W2320541894 @default.
• W3175269918 hasRelatedWork W2801040858 @default.
• W3175269918 hasRelatedWork W4232964041 @default.

• next